Published in Neuroinformatics on July 01, 2015
Automated segmentation of chronic stroke lesions using LINDA: Lesion identification with neighborhood data analysis. Hum Brain Mapp (2016) 0.79
Machine learning and computer vision approaches for phenotypic profiling. J Cell Biol (2016) 0.79
BIANCA (Brain Intensity AbNormality Classification Algorithm): A new tool for automated segmentation of white matter hyperintensities. Neuroimage (2016) 0.78
Location Sensitive Deep Convolutional Neural Networks for Segmentation of White Matter Hyperintensities. Sci Rep (2017) 0.77
T1- Thresholds in Black Holes Increase Clinical-Radiological Correlation in Multiple Sclerosis Patients. PLoS One (2015) 0.75
Aging of cerebral white matter. Ageing Res Rev (2016) 0.75
White matter lesions characterise brain involvement in moderate to severe chronic obstructive pulmonary disease, but cerebral atrophy does not. BMC Pulm Med (2017) 0.75
Prefrontal-Parietal White Matter Volumes in Healthy Elderlies Are Decreased in Proportion to the Degree of Cardiovascular Risk and Related to Inhibitory Control Deficits. Front Psychol (2017) 0.75
Evaluation of a deep learning approach for the segmentation of brain tissues and white matter hyperintensities of presumed vascular origin in MRI. Neuroimage Clin (2017) 0.75
Metric to quantify white matter damage on brain magnetic resonance images. Neuroradiology (2017) 0.75
Improved Automatic Segmentation of White Matter Hyperintensities in MRI Based on Multilevel Lesion Features. Neuroinformatics (2017) 0.75
Intraclass correlations: uses in assessing rater reliability. Psychol Bull (1979) 71.07
Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron (2002) 33.99
Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging (2001) 25.22
The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ (2010) 7.93
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol (2013) 6.18
The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology (1995) 3.95
Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology (2006) 3.68
Probabilistic segmentation of white matter lesions in MR imaging. Neuroimage (2004) 2.66
Lesion identification using unified segmentation-normalisation models and fuzzy clustering. Neuroimage (2008) 2.35
An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis. Neuroimage (2011) 2.31
Computer-assisted segmentation of white matter lesions in 3D MR images using support vector machine. Acad Radiol (2008) 2.25
FLAIR histogram segmentation for measurement of leukoaraiosis volume. J Magn Reson Imaging (2001) 2.24
A fully automated method for quantifying and localizing white matter hyperintensities on MR images. Psychiatry Res (2006) 2.08
Fully automatic segmentation of white matter hyperintensities in MR images of the elderly. Neuroimage (2005) 1.91
Markov random field segmentation of brain MR images. IEEE Trans Med Imaging (1997) 1.88
Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study. Stroke (2006) 1.88
New multispectral MRI data fusion technique for white matter lesion segmentation: method and comparison with thresholding in FLAIR images. Eur Radiol (2010) 1.76
Development of a semi-automated method for quantification of MRI gray and white matter lesions in geriatric subjects. Psychiatry Res (2002) 1.65
Fully-automated white matter hyperintensity detection with anatomical prior knowledge and without FLAIR. Inf Process Med Imaging (2009) 1.51
Review of automatic segmentation methods of multiple sclerosis white matter lesions on conventional magnetic resonance imaging. Med Image Anal (2012) 1.50
Regional white matter hyperintensity burden in automated segmentation distinguishes late-life depressed subjects from comparison subjects matched for vascular risk factors. Am J Psychiatry (2008) 1.50
Measuring progression of cerebral white matter lesions on MRI: visual rating and volumetrics. Neurology (2004) 1.46
Classification of white matter lesions on magnetic resonance imaging in elderly persons. Biol Psychiatry (2008) 1.45
Variable agreement between visual rating scales for white matter hyperintensities on MRI. Comparison of 13 rating scales in a poststroke cohort. Stroke (1997) 1.33
Quantitative assessment of MRI lesion load in multiple sclerosis. A comparison of conventional spin-echo with fast fluid-attenuated inversion recovery. Brain (1996) 1.27
Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques. Magn Reson Imaging (1996) 1.25
White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes. Eur Neurol (1998) 1.25
Quantitative approaches for assessment of white matter hyperintensities in elderly populations. Psychiatry Res (2011) 1.22
An automated procedure for the assessment of white matter hyperintensities by multispectral (T1, T2, PD) MRI and an evaluation of its between-centre reproducibility based on two large community databases. Neuroradiology (2007) 1.20
Lesion Explorer: a comprehensive segmentation and parcellation package to obtain regional volumetrics for subcortical hyperintensities and intracranial tissue. Neuroimage (2010) 1.19
A robust method for extraction and automatic segmentation of brain images. Neuroimage (2002) 1.17
Semiautomatic brain region extraction: a method of parcellating brain regions from structural magnetic resonance images. Neuroimage (2004) 1.14
White matter lesion extension to automatic brain tissue segmentation on MRI. Neuroimage (2009) 1.10
Measuring longitudinal white matter changes: comparison of a visual rating scale with a volumetric measurement. AJNR Am J Neuroradiol (2006) 1.08
Automatic segmentation of white matter hyperintensities in the elderly using FLAIR images at 3T. J Magn Reson Imaging (2010) 1.07
Segmentation of age-related white matter changes in a clinical multi-center study. Neuroimage (2008) 1.06
Towards the automatic computational assessment of enlarged perivascular spaces on brain magnetic resonance images: a systematic review. J Magn Reson Imaging (2013) 1.04
A comparison of different automated methods for the detection of white matter lesions in MRI data. Neuroimage (2011) 1.02
Automated white matter total lesion volume segmentation in diabetes. AJNR Am J Neuroradiol (2013) 0.99
Texture-based segmentation of diffuse lesions of the brain's white matter. Neuroimage (2007) 0.98
Automated detection and characterization of multiple sclerosis lesions in brain MR images. Magn Reson Imaging (1998) 0.98
Automatic segmentation of brain white matter and white matter lesions in normal aging: comparison of five multispectral techniques. Magn Reson Imaging (2011) 0.97
Fast spin-echo and fast fluid-attenuated inversion-recovery versus conventional spin-echo sequences for MR quantification of multiple sclerosis lesions. AJNR Am J Neuroradiol (1997) 0.95
MRI lesion volume measurement in multiple sclerosis and its correlation with disability: a comparison of fast fluid attenuated inversion recovery (fFLAIR) and spin echo sequences. J Neurol Neurosurg Psychiatry (1998) 0.88
Robust white matter lesion segmentation in FLAIR MRI. IEEE Trans Biomed Eng (2011) 0.87
Automatic segmentation of cerebral white matter hyperintensities using only 3D FLAIR images. Magn Reson Imaging (2013) 0.87
Complexity of MRI white matter hyperintensity assessments in relation to cognition in aging and dementia from the Sunnybrook Dementia Study. J Alzheimers Dis (2011) 0.87
Multi-stage segmentation of white matter hyperintensity, cortical and lacunar infarcts. Neuroimage (2012) 0.87
Relevance of hypointense lesions on fast fluid-attenuated inversion recovery MR images as a marker of disease severity in cases of multiple sclerosis. AJNR Am J Neuroradiol (1999) 0.87
Development and validation of morphological segmentation of age-related cerebral white matter hyperintensities. Neuroimage (2009) 0.87
Automatic white matter lesion segmentation using an adaptive outlier detection method. Magn Reson Imaging (2012) 0.85
Thalamic lesions in vascular dementia: low sensitivity of fluid-attenuated inversion recovery (FLAIR) imaging. Stroke (2004) 0.84
Do brain T2/FLAIR white matter hyperintensities correspond to myelin loss in normal aging? A radiologic-neuropathologic correlation study. Acta Neuropathol Commun (2013) 0.82
Automated quantification of white matter lesion in magnetic resonance imaging of patients with acute infarction. J Neurosci Methods (2012) 0.82
Interscanner variation in brain MR lesion load measurements in multiple sclerosis using conventional spin-echo, rapid relaxation-enhanced, and fast-FLAIR sequences. AJNR Am J Neuroradiol (1999) 0.82
Automated Bayesian segmentation of microvascular white-matter lesions in the ACCORD-MIND study. Adv Med Sci (2008) 0.81
Automatic segmentation of white matter hyperintensities by an extended FitzHugh & Nagumo reaction diffusion model. J Magn Reson Imaging (2012) 0.80
Segmentation of progressive multifocal leukoencephalopathy lesions in fluid-attenuated inversion recovery magnetic resonance imaging. J Neuroimaging (2001) 0.80
A vectorial image soft segmentation method based on neighborhood weighted Gaussian mixture model. Comput Med Imaging Graph (2009) 0.79
Computer-aided evaluation method of white matter hyperintensities related to subcortical vascular dementia based on magnetic resonance imaging. Comput Med Imaging Graph (2010) 0.78
Application of variable threshold intensity to segmentation for white matter hyperintensities in fluid attenuated inversion recovery magnetic resonance images. Neuroradiology (2014) 0.78
Contrast-based fully automatic segmentation of white matter hyperintensities: method and validation. PLoS One (2012) 0.77
Semi-automated thresholding technique for measuring lesion volumes in multiple sclerosis: effects of the change of the threshold on the computed lesion loads. Acta Neurol Scand (1996) 0.77
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet (2004) 7.45
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA (2006) 4.26
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study. Lancet Neurol (2011) 3.36
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. Lancet Neurol (2011) 2.44
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. JAMA Neurol (2013) 2.32
Large-scale replication and heterogeneity in Parkinson disease genetic loci. Neurology (2012) 2.18
Further evidence that SPG3A gene mutations cause autosomal dominant hereditary spastic paraplegia. Ann Neurol (2002) 2.07
Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. Brain (2010) 2.01
Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders. Nat Genet (2003) 1.99
Volume and iron content in basal ganglia and thalamus. Hum Brain Mapp (2009) 1.85
Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. Brain (2012) 1.67
Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability. J Neurol Sci (2007) 1.61
Accuracy of magnetic resonance parkinsonism index for differentiation of progressive supranuclear palsy from probable or possible Parkinson disease. Mov Disord (2011) 1.56
UCHL1 is a Parkinson's disease susceptibility gene. Ann Neurol (2004) 1.54
Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy. Mov Disord (2008) 1.48
Compound heterozygosity in DJ-1 gene non-coding portion related to parkinsonism. Parkinsonism Relat Disord (2008) 1.45
Blocking out the real diagnosis. Lancet (2011) 1.43
Monoamine oxidase-a genetic variations influence brain activity associated with inhibitory control: new insight into the neural correlates of impulsivity. Biol Psychiatry (2005) 1.41
Independent and joint effects of the MAPT and SNCA genes in Parkinson disease. Ann Neurol (2011) 1.40
Single nucleotide polymorphism in the MMP-9 gene is associated with susceptibility to develop multiple sclerosis in an Italian case-control study. J Neuroimmunol (2010) 1.39
Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures. Proc Natl Acad Sci U S A (2005) 1.32
DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex. Ann Neurol (2005) 1.29
Increased prefrontal volume in PD with levodopa-induced dyskinesias: a voxel-based morphometry study. Mov Disord (2011) 1.27
Prefrontal alterations in Parkinson's disease with levodopa-induced dyskinesia during fMRI motor task. Mov Disord (2011) 1.23
Non-invasive brain-computer interface system: towards its application as assistive technology. Brain Res Bull (2008) 1.22
Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis. Clin Neuropharmacol (2004) 1.14
Callosal atrophy in mild cognitive impairment and Alzheimer's disease: different effects in different stages. Neuroimage (2009) 1.13
C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population. Neurobiol Aging (2012) 1.13
Usefulness of a morning routine EEG recording in patients with juvenile myoclonic epilepsy. Epilepsy Res (2007) 1.12
Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Parkinsonism Relat Disord (2011) 1.11
Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism. Hum Mutat (2013) 1.10
Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis. J Neurol (2004) 1.10
Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease. Mov Disord (2008) 1.08
Which is the goal of cognitive rehabilitation in multiple sclerosis: the improvement of cognitive performance or the perception of cognitive deficits? Mult Scler (2013) 1.07
Validation of the Italian version of the Movement Disorder Society--Unified Parkinson's Disease Rating Scale. Neurol Sci (2012) 1.06
Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study. Arch Neurol (2005) 1.06
Education mediates microstructural changes in bilateral hippocampus. Hum Brain Mapp (2011) 1.05
Comparison of different MR venography techniques for detecting transverse sinus stenosis in idiopathic intracranial hypertension. J Neurol (2005) 1.05
Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis? Neurosci Lett (2004) 1.04
Reduced fronto-temporal connectivity is associated with frontal gray matter density reduction and neuropsychological deficit in schizophrenia. Schizophr Res (2008) 1.03
Clinical and genetic findings in 26 Italian patients with Lafora disease. Epilepsia (2006) 1.03
Neocortical thinning in "benign" mesial temporal lobe epilepsy. Epilepsia (2011) 1.02
Hippocampi, thalami, and accumbens microstructural damage in schizophrenia: a volumetry, diffusivity, and neuropsychological study. Schizophr Bull (2009) 0.99
Non-replication of association for six polymorphisms from meta-analysis of genome-wide association studies of Parkinson's disease: large-scale collaborative study. Am J Med Genet B Neuropsychiatr Genet (2010) 0.99
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol [EudraCT no.: 2006-000032-27]. Pharmacol Res (2006) 0.99
The gender effect in juvenile Huntington disease patients of Italian origin. Am J Med Genet B Neuropsychiatr Genet (2004) 0.99
Hippocampal mean diffusivity and memory in healthy elderly individuals: a cross-sectional study. Neurology (2010) 0.97
Correlation between clinical/neurophysiological findings and quality of life in Charcot-Marie-Tooth type 1A. J Peripher Nerv Syst (2008) 0.97
Altered cortical-cerebellar circuits during verbal working memory in essential tremor. Brain (2011) 0.96
Impact of catechol-O-methyltransferase Val(108/158) Met genotype on hippocampal and prefrontal gray matter volume. Neuroreport (2008) 0.96
Voxel-based morphometry of sporadic epileptic patients with mesiotemporal sclerosis. Epilepsia (2009) 0.96
Computer-assisted cognitive rehabilitation of attention deficits for multiple sclerosis: a randomized trial with fMRI correlates. Neurorehabil Neural Repair (2012) 0.95
Neuroanatomic correlates of psychogenic nonepileptic seizures: a cortical thickness and VBM study. Epilepsia (2011) 0.95
A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease. Neurobiol Aging (2009) 0.95
Body weight influences pharmacokinetics of levodopa in Parkinson's disease. Clin Neuropharmacol (2002) 0.95
Genetically dependent modulation of serotonergic inactivation in the human prefrontal cortex. Neuroimage (2007) 0.94
Sporadic ALS is not associated with VAPB gene mutations in Southern Italy. J Negat Results Biomed (2006) 0.94
Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease. Brain Res Bull (2007) 0.93
The effects of BDNF Val66Met polymorphism on brain function in controls and patients with multiple sclerosis: an imaging genetic study. Behav Brain Res (2009) 0.93
Seeking Huntington disease biomarkers by multimodal, cross-sectional basal ganglia imaging. Hum Brain Mapp (2012) 0.93
Leukemia risk in children exposed to benzene and PM10 from vehicular traffic: a case-control study in an Italian population. Eur J Epidemiol (2012) 0.93
Genetic heterogeneity in patients with pantothenate kinase-associated neurodegeneration and classic magnetic resonance imaging eye-of-the-tiger pattern. Mov Disord (2006) 0.92
Neuroimaging of Essential Tremor: What is the Evidence for Cerebellar Involvement? Tremor Other Hyperkinet Mov (N Y) (2012) 0.92
Neurobiological mechanisms underlying emotional processing in relapsing-remitting multiple sclerosis. Brain (2009) 0.92
Serial MRI findings in brain anoxia leading to Lance-Adams syndrome: a case report. Neurol Sci (2013) 0.92
Levetiracetam in patients with generalised epilepsy and myoclonic seizures: an open label study. Seizure (2006) 0.91
Mutational analysis of EFHC1 gene in Italian families with juvenile myoclonic epilepsy. Epilepsia (2007) 0.91
A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants. J Med Genet (2012) 0.90
Voluptuary habits and clinical subtypes of Parkinson's disease: the FRAGAMP case-control study. Mov Disord (2010) 0.90
MR imaging of middle cerebellar peduncle width: differentiation of multiple system atrophy from Parkinson disease. Radiology (2006) 0.90
Charcot-Marie-Tooth and pain: correlations with neurophysiological, clinical, and disability findings. Neurol Sci (2008) 0.89
Voxel-based analysis of R2* maps in the healthy human brain. J Magn Reson Imaging (2007) 0.89
Ventro-lateral prefrontal activity during working memory is modulated by MAO A genetic variation. Brain Res (2008) 0.89
Two novel SCN1A missense mutations in generalized epilepsy with febrile seizures plus. Epilepsia (2003) 0.89
Neurofunctional correlates of attention rehabilitation in Parkinson's disease: an explorative study. Neurol Sci (2014) 0.89
Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants. Neurobiol Aging (2013) 0.89
A phenotypic variation of dominant optic atrophy and deafness (ADOAD) due to a novel OPA1 mutation. J Neurol (2008) 0.89
Spinal glioneuronal tumor with neuropil-like islands and meningeal dissemination: histopathological and radiological study of a pediatric case. Neuropathology (2008) 0.88
Parkinsonism and essential tremor in a family with pseudo-dominant inheritance of PARK2: an FP-CIT SPECT study. Mov Disord (2007) 0.88
Brain iron deposition in essential tremor: a quantitative 3-Tesla magnetic resonance imaging study. Mov Disord (2012) 0.88
Electroclinical features of a family with simple febrile seizures and temporal lobe epilepsy associated with SCN1A loss-of-function mutation. Epilepsia (2007) 0.88
White matter microstructure and apathy level in amnestic mild cognitive impairment. J Alzheimers Dis (2010) 0.88
Mental representations of action: the neural correlates of the verbal and motor components. Brain Res (2010) 0.88
A Cellular Neural Network methodology for the automated segmentation of multiple sclerosis lesions. J Neurosci Methods (2011) 0.88
Object naming and action-verb generation in Parkinson's disease: a fMRI study. Cortex (2009) 0.87
Interaction between Apolipoprotein epsilon 4 and traumatic brain injury in patients with Alzheimer's disease and Mild Cognitive Impairment. Funct Neurol (2007) 0.87
Serotonin transporter gene (5-Htt): association analysis with temporal lobe epilepsy. Neurosci Lett (2007) 0.87
ApoE epsilon4 allele and disease duration affect verbal learning in mild temporal lobe epilepsy. Epilepsia (2005) 0.87
Diffusion tensor MRI to investigate dementias: a brief review. Magn Reson Imaging (2007) 0.87
Natural history of neurofibromatosis type 2 with onset before the age of 1 year. Neurogenetics (2013) 0.87
COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson's disease (PD): relevance for motor and non-motor features. Neuropsychiatr Dis Treat (2008) 0.86
Dysbindin C-A-T haplotype is associated with thicker medial orbitofrontal cortex in healthy population. Neuroimage (2010) 0.85
Leber's hereditary optic neuropathy associated with a multiple-sclerosis-like picture in a man. Mult Scler (2011) 0.85
Age at onset influences neurodegenerative processes underlying PD with levodopa-induced dyskinesias. Parkinsonism Relat Disord (2013) 0.84
Temporal lobe epilepsy as a unique manifestation of multiple sclerosis. Can J Neurol Sci (2003) 0.84